Operaciones Dyadic International, Inc. - DYAI CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.1392 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Estadísticas clave
| Cierre previo* | 1.294 |
| Abrir* | 1.3036 |
| Cambio de 1 año* | -59.39% |
| Rango del día* | 1.2554 - 1.3038 |
| Rango de 52 semanas | 1.12-3.56 |
| Volumen medio (10 días) | 34.15K |
| Volumen medio (3 meses) | 626.73K |
| Capitalización de mercado | 38.13M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 28.56M |
| Ingresos | 2.50M |
| EPS | -0.42 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 0.64 |
| Próxima fecha de resultados | Mar 29, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Mar 23, 2023 | 1.2554 | -0.0482 | -3.70% | 1.3036 | 1.3038 | 1.2456 |
| Mar 22, 2023 | 1.2940 | 0.0774 | 6.36% | 1.2166 | 1.3038 | 1.2166 |
| Mar 21, 2023 | 1.3036 | 0.0105 | 0.81% | 1.2931 | 1.3229 | 1.2836 |
| Mar 20, 2023 | 1.2746 | 0.0769 | 6.42% | 1.1977 | 1.2938 | 1.1973 |
| Mar 17, 2023 | 1.1885 | -0.1149 | -8.82% | 1.3034 | 1.3034 | 1.1785 |
| Mar 16, 2023 | 1.2936 | -0.0473 | -3.53% | 1.3409 | 1.3417 | 1.2164 |
| Mar 15, 2023 | 1.3319 | -0.0188 | -1.39% | 1.3507 | 1.3899 | 1.3217 |
| Mar 14, 2023 | 1.4092 | -0.1718 | -10.87% | 1.5810 | 1.6010 | 1.4080 |
| Mar 13, 2023 | 1.5812 | 0.2211 | 16.26% | 1.3601 | 1.6106 | 1.3601 |
| Mar 10, 2023 | 1.4374 | -0.0867 | -5.69% | 1.5241 | 1.5914 | 1.4178 |
| Mar 9, 2023 | 1.5431 | -0.1146 | -6.91% | 1.6577 | 1.6777 | 1.5233 |
| Mar 8, 2023 | 1.6390 | 0.0192 | 1.19% | 1.6198 | 1.6392 | 1.5229 |
| Mar 7, 2023 | 1.5421 | 0.2106 | 15.82% | 1.3315 | 1.6202 | 1.3315 |
| Mar 6, 2023 | 1.3323 | -0.1047 | -7.29% | 1.4370 | 1.4378 | 1.3029 |
| Mar 3, 2023 | 1.3994 | 0.0585 | 4.36% | 1.3409 | 1.3997 | 1.3409 |
| Mar 2, 2023 | 1.3417 | -0.0859 | -6.02% | 1.4276 | 1.4378 | 1.3315 |
| Mar 1, 2023 | 1.4378 | 0.0969 | 7.23% | 1.3409 | 1.4378 | 1.3409 |
| Feb 28, 2023 | 1.3129 | 0.1148 | 9.58% | 1.1981 | 1.3134 | 1.1883 |
| Feb 27, 2023 | 1.1885 | -0.0002 | -0.02% | 1.1887 | 1.1983 | 1.1307 |
| Feb 24, 2023 | 1.1881 | -0.0194 | -1.61% | 1.2075 | 1.2271 | 1.1881 |
Dyadic International, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos totales | 2.40383 | 1.60192 | 1.68108 | 1.29545 | 0.75842 |
| Ingresos | 2.40383 | 1.60192 | 1.68108 | 1.29545 | 0.75842 |
| Coste de los ingresos, total | 1.94444 | 1.42493 | 1.4597 | 1.02728 | 0.6802 |
| Beneficio bruto | 0.45939 | 0.17699 | 0.22138 | 0.26817 | 0.07822 |
| Gastos totales de explotación | 17.1313 | 11.6276 | 10.9637 | 8.8879 | 3.52708 |
| Gastos de venta/general/administración Gastos, total | 6.69762 | 6.0848 | 5.51992 | 4.52268 | 5.03035 |
| Investigación y desarrollo | 8.39237 | 3.86812 | 3.95632 | 3.31716 | 2.2031 |
| Gasto (ingreso) por intereses - Explotación neta | 0.09689 | 0.06235 | 0.02773 | 0.02078 | -0.24906 |
| Gastos (ingresos) extraordinarios | 0 | -4.35822 | |||
| Other Operating Expenses, Total | 0 | 0.18739 | 0 | 0.22072 | |
| Ingresos de explotación | -14.7275 | -10.0257 | -9.28259 | -7.59245 | -2.76866 |
| Ingresos por intereses (gastos), netos No operativos | 1.65724 | 0.73171 | 0.98493 | 0.89453 | 0.56615 |
| Ingresos netos antes de impuestos | -13.0702 | -9.29396 | -8.29766 | -6.69791 | -2.20251 |
| Ingresos netos después de impuestos | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Beneficio neto antes de partidas extra. Elementos | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Total de partidas extraordinarias | -0.8 | ||||
| Ingresos netos | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -1.33582 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Beneficio neto diluido | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Promedio ponderado de acciones diluidas | 27.8381 | 27.4716 | 27.0037 | 27.6733 | 28.918 |
| BPA diluido sin partidas extraordinarias | -0.46951 | -0.33945 | -0.30766 | -0.20568 | -0.04619 |
| BPA normalizado diluido | -0.46951 | -0.33945 | -0.30766 | -0.20568 | -0.14415 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Ingresos totales | 0.64843 | 0.31329 | 0.69293 | 0.93709 | 0.46052 |
| Ingresos | 0.64843 | 0.31329 | 0.69293 | 0.93709 | 0.46052 |
| Coste de los ingresos, total | 0.40475 | 0.33163 | 0.39254 | 0.8295 | 0.39076 |
| Beneficio bruto | 0.24368 | -0.01834 | 0.30039 | 0.10759 | 0.06976 |
| Gastos totales de explotación | 3.39306 | 4.52908 | 4.01693 | 4.80417 | 3.78114 |
| Gastos de venta/general/administración Gastos, total | 1.6557 | 1.70316 | 1.69284 | 1.74761 | 1.55401 |
| Investigación y desarrollo | 1.34286 | 2.47348 | 1.90155 | 2.20924 | 1.8081 |
| Gasto (ingreso) por intereses - Explotación neta | -0.01025 | 0.02081 | 0.03 | 0.01781 | 0.02827 |
| Ingresos de explotación | -2.74463 | -4.21579 | -3.324 | -3.86708 | -3.32062 |
| Ingresos por intereses (gastos), netos No operativos | 0.00297 | 1.60746 | 0.0032 | 0.0209 | 0.02567 |
| Ingresos netos antes de impuestos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Ingresos netos después de impuestos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Beneficio neto antes de partidas extra. Elementos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Ingresos netos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Beneficio neto diluido | -2.49167 | -4.21386 | -1.71527 | -3.84617 | -3.29495 |
| Promedio ponderado de acciones diluidas | 28.2513 | 28.0884 | 28.0792 | 27.6454 | 27.5333 |
| BPA diluido sin partidas extraordinarias | -0.0882 | -0.15002 | -0.06109 | -0.13913 | -0.11967 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.0882 | -0.15002 | -0.06109 | -0.13913 | -0.11967 |
| Other Operating Expenses, Total | 0 | 0 | 0 | ||
| Otros, netos | 0.25 | -1.60553 | 1.60553 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 21.0083 | 29.7815 | 35.6392 | 42.7481 | 49.6158 |
| Efectivo e inversiones a corto plazo | 20.2603 | 29.0945 | 34.2227 | 41.2028 | 47.6851 |
| Efectivo y Equivalentes | 15.7485 | 20.6371 | 4.82354 | 2.38631 | 5.78635 |
| Inversiones a corto plazo | 4.51178 | 8.45745 | 29.3992 | 38.8164 | 41.8988 |
| Total deudores, neto | 0.37221 | 0.40645 | 1.31244 | 1.11985 | 0.76087 |
| Accounts Receivable - Trade, Net | 0.27783 | 0.2942 | 0.55853 | 0.31874 | 0.27103 |
| Prepaid Expenses | 0.37583 | 0.28056 | 0.10411 | 0.42545 | 1.1698 |
| Other Current Assets, Total | 0 | ||||
| Total Assets | 21.2991 | 30.0724 | 37.4525 | 43.3008 | 50.7442 |
| Long Term Investments | 0.28471 | 0.28471 | 1.51164 | 0 | 0.92265 |
| Other Long Term Assets, Total | 0.00612 | 0.00623 | 0.05131 | 0.05214 | 0.20574 |
| Total Current Liabilities | 2.55572 | 1.62587 | 1.58803 | 0.84964 | 0.7689 |
| Accounts Payable | 0.30906 | 0.52026 | |||
| Accrued Expenses | 0.70956 | 0.48976 | 0.566 | 0.39958 | 0.14796 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.84616 | 1.13612 | 1.02202 | 0.141 | 0.10068 |
| Total Liabilities | 2.90866 | 1.62587 | 1.58803 | 0.84964 | 0.7689 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 18.3905 | 28.4466 | 35.8645 | 42.4512 | 49.9753 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 0.04048 | 0.03975 | 0.03961 | 0.03897 | 0.03894 |
| Additional Paid-In Capital | 101.026 | 98.0131 | 96.1059 | 94.3852 | 93.9136 |
| Retained Earnings (Accumulated Deficit) | -63.7466 | -50.6763 | -41.3511 | -33.0431 | -27.3514 |
| Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -16.6259 |
| Other Equity, Total | |||||
| Total Liabilities & Shareholders’ Equity | 21.2991 | 30.0724 | 37.4525 | 43.3008 | 50.7442 |
| Total Common Shares Outstanding | 28.2292 | 27.4942 | 27.3592 | 26.7135 | 28.3278 |
| Note Receivable - Long Term | 0 | 0.25031 | 0.50062 | ||
| Other Liabilities, Total | 0.35294 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 16.2413 | 21.0083 | 23.5722 | 26.1564 | 27.9914 |
| Efectivo e inversiones a corto plazo | 15.4401 | 20.2603 | 22.7478 | 25.6007 | 27.233 |
| Efectivo y Equivalentes | 12.419 | 15.7485 | 13.6606 | 14.0188 | 13.0556 |
| Inversiones a corto plazo | 3.02106 | 4.51178 | 9.0872 | 11.5819 | 14.1774 |
| Total deudores, neto | 0.55705 | 0.37221 | 0.25443 | 0.45475 | 0.54216 |
| Accounts Receivable - Trade, Net | 0.52815 | 0.27783 | 0.17963 | 0.29144 | 0.38496 |
| Prepaid Expenses | 0.24417 | 0.37583 | 0.56997 | 0.10089 | 0.21619 |
| Total Assets | 18.5302 | 21.2991 | 23.8631 | 26.4473 | 28.2822 |
| Long Term Investments | 2.28283 | 0.28471 | 0.28471 | 0.28471 | 0.28471 |
| Other Long Term Assets, Total | 0.0061 | 0.00612 | 0.00614 | 0.00617 | 0.00615 |
| Total Current Liabilities | 1.82648 | 2.55572 | 1.96293 | 3.28849 | 2.59373 |
| Accrued Expenses | 0.53301 | 0.70956 | 0.84245 | 0.5948 | 0.27767 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.29347 | 1.84616 | 1.12048 | 2.69368 | 2.31606 |
| Total Liabilities | 2.1353 | 2.90866 | 1.96293 | 3.28849 | 2.59373 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 16.3949 | 18.3905 | 21.9001 | 23.1588 | 25.6885 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.04052 | 0.04048 | 0.04033 | 0.04033 | 0.03981 |
| Additional Paid-In Capital | 101.523 | 101.026 | 100.322 | 99.8658 | 98.5499 |
| Retained Earnings (Accumulated Deficit) | -66.2383 | -63.7466 | -59.5327 | -57.8175 | -53.9713 |
| Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
| Total Liabilities & Shareholders’ Equity | 18.5302 | 21.2991 | 23.8631 | 26.4473 | 28.2822 |
| Total Common Shares Outstanding | 28.2642 | 28.2292 | 28.0792 | 28.0792 | 27.5542 |
| Other Liabilities, Total | 0.30882 | 0.35294 |
- Anual
- Trimestral
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -13.0702 | -9.32527 | -8.30797 | -5.69176 | -2.13582 |
| Efectivo de actividades de explotación | -11.2769 | -6.57439 | -5.78289 | -4.40719 | -1.69117 |
| Partidas no monetarias | 0.60508 | 1.76081 | 1.39701 | 1.16463 | 1.28542 |
| Cash Taxes Paid | 0 | -0.50062 | -0.50687 | 0 | 0.16374 |
| Intereses pagados en efectivo | |||||
| Cambios en el capital circulante | 1.18823 | 0.99008 | 1.12806 | 0.11994 | -0.84078 |
| Efectivo de actividades de inversión | 5.22159 | 22.122 | 7.70745 | 3.32832 | -0.81208 |
| Otras partidas de flujo de caja de inversión, total | 5.22159 | 22.122 | 7.70745 | 3.32832 | -0.81208 |
| Efectivo procedente de actividades de financiación | 1.23005 | 0.25547 | 0.55019 | -2.29954 | -6.22253 |
| Elementos de flujo de caja de financiación | |||||
| Emisión (retiro) de acciones, neto | 1.23005 | 0.25547 | 0.55019 | -2.29954 | -6.22253 |
| Emisión (amortización) de deuda, neta | |||||
| Variación neta de la tesorería | -4.88857 | 15.8135 | 2.43723 | -3.40003 | -8.46787 |
| Efectos del cambio de divisas | -0.06326 | 0.01037 | -0.03752 | -0.02162 | 0.25792 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -2.49167 | -13.0702 | -8.85639 | -7.14112 | -3.29495 |
| Cash From Operating Activities | -2.85038 | -11.2769 | -8.64188 | -4.30778 | -1.90651 |
| Non-Cash Items | 0.45699 | 0.60508 | 0.04914 | 1.07275 | 0.51329 |
| Changes in Working Capital | -0.81571 | 1.18823 | 0.16537 | 1.76059 | 0.87514 |
| Cash From Investing Activities | -0.52085 | 5.22159 | 0.72159 | -3.28394 | -5.78394 |
| Other Investing Cash Flow Items, Total | -0.52085 | 5.22159 | 0.72159 | -3.28394 | -5.78394 |
| Cash From Financing Activities | 0.04235 | 1.23005 | 0.98555 | 0.98614 | 0.1158 |
| Issuance (Retirement) of Stock, Net | 0.04235 | 1.23005 | 0.98555 | 0.98614 | 0.1158 |
| Foreign Exchange Effects | -0.00057 | -0.06326 | -0.0417 | -0.01264 | -0.00683 |
| Net Change in Cash | -3.32945 | -4.88857 | -6.97643 | -6.61822 | -7.58149 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Emalfarb (Mark A) | Individual Investor | 16.3532 | 4670971 | 138478 | 2023-01-03 | |
| Francisco Trust | Corporation | 12.4235 | 3548528 | 0 | 2022-12-31 | LOW |
| Bandera Partners LLC | Investment Advisor/Hedge Fund | 5.4858 | 1566908 | 0 | 2022-12-31 | LOW |
| Chapin Davis Asset Management | Investment Advisor | 2.8695 | 819629 | 819629 | 2022-12-31 | |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6397 | 753974 | 423 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.885 | 252791 | 815 | 2022-12-31 | LOW |
| Northeast Financial Consultants Inc | Investment Advisor | 0.8753 | 250000 | 0 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7499 | 214208 | 3993 | 2022-12-31 | LOW |
| Tarnok (Michael P) | Individual Investor | 0.6614 | 188929 | 0 | 2022-04-14 | LOW |
| DIM Funds SICAV S.A. | Hedge Fund | 0.4796 | 137000 | 137000 | 2021-12-31 | |
| Sage Mountain Advisors, LLC | Investment Advisor | 0.3731 | 106564 | 0 | 2022-12-31 | MED |
| Herbst (Seth J. M.D.) | Individual Investor | 0.3676 | 105000 | 50000 | 2022-04-14 | MED |
| Rawson (Ping Wang) | Individual Investor | 0.2971 | 84851 | 39351 | 2023-01-03 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2693 | 76910 | -23764 | 2022-12-31 | HIGH |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.2078 | 59355 | 7381 | 2022-12-31 | LOW |
| Hazelton (Joseph P) | Individual Investor | 0.2011 | 57448 | 57448 | 2023-01-03 | |
| Forefront Analytics, LLC | Investment Advisor/Hedge Fund | 0.1999 | 57094 | 16548 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.198 | 56550 | 0 | 2022-12-31 | LOW |
| Pekin Hardy Strauss Wealth Management | Investment Advisor | 0.172 | 49130 | -2110 | 2022-12-31 | LOW |
| Perkins Capital Management, Inc. | Investment Advisor | 0.1684 | 48100 | 0 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Dyadic International, Inc. Company profile
Sobre Dyadic International, Inc.
Dyadic International, Inc. es una empresa de plataformas biotecnológicas. La empresa se centra en el desarrollo de la plataforma C1 para su uso en aplicaciones farmacéuticas humanas y animales en todo el mundo. La tecnología de la plataforma C1 se basa en el hongo Myceliopthora thermophila, que la empresa ha denominado C1. La plataforma de expresión génica C1 se utiliza en el descubrimiento, desarrollo y fabricación de medicamentos biológicos y vacunas. La tecnología C1 es un sistema de expresión fúngica para el descubrimiento, desarrollo y producción de enzimas y otras proteínas. La tecnología C1 es una solución comercialmente disponible para captar genes y desarrollar procesos industriales para producir volúmenes de enzimas y otros productos proteicos. La empresa también está trabajando en oportunidades de vacunas y anticuerpos relacionados con COVID-19, incluyendo el candidato a vacuna de COVID-19, DYAI-100.
| Industry: | Biotechnology & Medical Research (NEC) |
140 Intracoastal Pointe Dr Ste 404
JUPITER
FLORIDA 33477
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com